Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
1.800
0.00 (0.00%)
Dec 5, 2025, 4:00 PM EST - Market closed
Palisade Bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2018 |
| Revenue | - | - | 0.25 | - | - | - | Upgrade
|
| Gross Profit | - | - | 0.25 | - | - | - | Upgrade
|
| Selling, General & Admin | 5.35 | 5.8 | 6.2 | 8.76 | 9.31 | 6.2 | Upgrade
|
| Research & Development | 6.1 | 9.06 | 6.89 | 6.55 | 2.43 | 3.1 | Upgrade
|
| Operating Expenses | 11.46 | 14.86 | 13.1 | 15.31 | 11.74 | 9.3 | Upgrade
|
| Operating Income | -11.46 | -14.86 | -12.85 | -15.31 | -11.74 | -9.3 | Upgrade
|
| Interest Expense | -0.01 | -0.01 | -0.02 | -0.01 | -3.08 | -1.08 | Upgrade
|
| Interest & Investment Income | 0.5 | 0.5 | 0.7 | 0.2 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0.26 | -0.07 | 0.09 | 1.27 | 18.04 | 0.05 | Upgrade
|
| EBT Excluding Unusual Items | -11.23 | -14.44 | -12.08 | -13.85 | 3.22 | -10.32 | Upgrade
|
| Merger & Restructuring Charges | - | - | -0.23 | -0.41 | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | 0.28 | - | Upgrade
|
| Pretax Income | -11.23 | -14.44 | -12.3 | -14.26 | -26.62 | -10.32 | Upgrade
|
| Net Income | -11.23 | -14.44 | -12.3 | -14.26 | -26.62 | -10.32 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | 0.02 | 0.29 | - | - | Upgrade
|
| Net Income to Common | -11.23 | -14.44 | -12.32 | -14.55 | -26.62 | -10.32 | Upgrade
|
| Shares Outstanding (Basic) | 5 | 1 | 0 | 0 | 0 | - | Upgrade
|
| Shares Outstanding (Diluted) | 5 | 1 | 0 | 0 | 0 | - | Upgrade
|
| Shares Change (YoY) | 367.35% | 210.62% | 677.03% | 370.85% | - | - | Upgrade
|
| EPS (Basic) | -2.33 | -10.19 | -27.01 | -247.89 | -2144.20 | - | Upgrade
|
| EPS (Diluted) | -2.33 | -10.19 | -27.01 | -247.95 | -2546.13 | - | Upgrade
|
| Free Cash Flow | -10.08 | -12.19 | -11.14 | -13.37 | -14.77 | -4.77 | Upgrade
|
| Free Cash Flow Per Share | -2.09 | -8.61 | -24.42 | -227.82 | -1185.25 | - | Upgrade
|
| Gross Margin | - | - | 100.00% | - | - | - | Upgrade
|
| Operating Margin | - | - | -5138.00% | - | - | - | Upgrade
|
| Profit Margin | - | - | -4926.40% | - | - | - | Upgrade
|
| Free Cash Flow Margin | - | - | -4454.80% | - | - | - | Upgrade
|
| EBITDA | -11.45 | -14.86 | -12.84 | -15.31 | -11.74 | -9.29 | Upgrade
|
| D&A For EBITDA | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| EBIT | -11.46 | -14.86 | -12.85 | -15.31 | -11.74 | -9.3 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.